Evidence-based recommendations on the RD-100i OSNA system and Metasin test for detecting sentinel lymph node metastases in people having breast cancer surgery
NICE has assessed 3 viscoelastometric point-of-care testing devices (the ROTEM, TEG and Sonoclot systems), to help the NHS decide whether to use these products
Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits)
Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the
Evidence-based recommendations on testing for epidermal growth factor receptor tyrosine kinase (EGFR–TK) mutations in untreated, locally advanced or metastatic
In development [GID-DG10034] Expected publication date: 17 February 2021
In development [GID-DG10029] Expected publication date: 13 January 2021
Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. The tests are
In development [GID-SGWAVE0702] Expected publication date: TBC
In development [GID-SGWAVE0701] Expected publication date: TBC
In development [GID-SGWAVE0700] Expected publication date: TBC
In development [GID-SGWAVE0761] Expected publication date: TBC
In development [GID-SGWAVE0762] Expected publication date: TBC
In development [GID-IP1046] Expected publication date: TBC
In development [GID-IPG10171] Expected publication date: TBC